Triangle Capital Corporation (NYSE:TCAP) has launched a stock offering expected to net $67 million that the specialty finance company will use to make more investments in businesses.
The offering of 3.7 million shares was priced at $19 per share. Underwriters have a 30-day option to purchase up to 555,000 additional shares to cover any over allotments. The offering is subject to customary closing conditions and is expected to close on Feb. 13.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Raleigh, North Carolina-based Triangle Capital focuses on lower middle-market companies, which the firm defines as companies with revenue between $10 million and $100 million, and earnings between $3 million and $20 million. Triangle Capital invests in companies in a wide range of industries; though the firm doesn’t target pharmaceutical or medical device developers, it does have some healthcare investments. Last year, the firm pumped $11.5 million into Chicago-based Home Health Physicians, a company that provides healthcare to patients unable to travel to a doctor’s office.
Other Triangle Capital portfolio companies in the healthcare space include TBG Anesthesia Management, a Midwest-based physician management company that provides contracted outsourced anesthesiology services to hospitals and medical centers, and Genapure, a Florida-based provider of lab testing services whose clients include pharmaceutical firms. Through the third quarter of 2011, Triangle Capital’s investments in 60 portfolio companies was valued at $464.4 million.
Underwriters for the stock offering are Morgan Stanley & Co., Morgan Keegan & Company, Robert W. Baird & Co., BB&T Capital Markets, a division of Scott & Stringfellow, Janney Montgomery Scott LLC, JMP Securities, and Sterne, Agee & Leach.